Additional file 1: of Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis

Plasma neurofilaments correlate with disability in progressive multiple sclerosis patients

Ferraro, Diana
Guicciardi, Claudio
De Biasi, Sara
Pinti, Marcello
Bedin, Roberta
Camera, Valentina
Vitetta, Francesca
Nasi, Milena
Meletti, Stefano
Sola, Patrizia

January 2020

Cerebrospinal fluid (CSF) and blood neurofilaments (NFLs) are markers of axonal damage and are being...

Additional file 2: Table S2. of Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis

Michael Gurevich (128754)
Gadi Miron (3430016)
Rina Zilkha Falb (3430013)
David Magalashvili (128751)
Mark Dolev (128752)
Yael Stern (440380)
Anat Achiron (71228)

November 2015

List of DEGs characterizing SPMS untreated vs. RRMS untreated patients. (XLSX 21 kb

Additional file 1 of Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias

Giuseppe Mario Bentivenga (13946676)
Simone Baiardi (3544532)
Andrea Mastrangelo (11594374)
Corrado Zenesini (781399)
Angela Mammana (2160655)
Barbara Polischi (4796133)
Sabina Capellari (324583)
Piero Parchi (324582)

September 2023

Additional file 1: Supplementary material. Supplementary methods, probable sCJD and np-RPD patients’...

Additional file 2: of Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis

Irene HĂĽkansson (5534792)
Anders Tisell (307389)
Petra Cassel (5534786)
Kaj Blennow (58615)
Henrik Zetterberg (144718)
Peter Lundberg (307397)
Charlotte Dahle (307394)
Magnus Vrethem (307399)
Jan Ernerudh (45215)

July 2018

Table S2. Neuroinflammatory and neurodegenerative markers with respect to separation of patients wit...

Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis

Håkansson, Irene
Tisell, Anders
Cassel, Petra
Blennow, Kaj
Zetterberg, Henrik
Lundberg, Peter
Dahle, Charlotte
Vrethem, Magnus
Ernerudh, Jan

January 2018

Background: There is a need for clinically useful biomarkers of disease activity in clinically isola...

Additional file 1: of Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study

M. Olesen (6446813)
K. Soelberg (6446816)
B. Debrabant (6446819)
A. Nilsson (4329301)
S. Lillevang (6446825)
J. Grauslund (6446828)
I. Brandslund (6446831)
J. Madsen (2052997)
F. Paul (4171135)
T. Smith (3484139)
S. Jarius (4171156)
N. Asgari (6446834)

March 2019

Figure S1. Correlation between intrathecal markers in isolated optic neuritis. This figure depicts t...

Additional file 2: of Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study

M. Olesen (6446813)
K. Soelberg (6446816)
B. Debrabant (6446819)
A. Nilsson (4329301)
S. Lillevang (6446825)
J. Grauslund (6446828)
I. Brandslund (6446831)
J. Madsen (2052997)
F. Paul (4171135)
T. Smith (3484139)
S. Jarius (4171156)
N. Asgari (6446834)

March 2019

Table S1. Logistic regression analyses for single predictors. Highlighted in bold are p values for w...

Additional file 3: of Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study

M. Olesen (6446813)
K. Soelberg (6446816)
B. Debrabant (6446819)
A. Nilsson (4329301)
S. Lillevang (6446825)
J. Grauslund (6446828)
I. Brandslund (6446831)
J. Madsen (2052997)
F. Paul (4171135)
T. Smith (3484139)
S. Jarius (4171156)
N. Asgari (6446834)

March 2019

Figure S2. Receiver-operating characteristic (ROC) curves for the six individual predictors that wer...

Additional file 2 of Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model

Tianrong Yeo (4664314)
Halwan Bayuangga (13931168)
Marcus Augusto-Oliveira (5565137)
Megan Sealey (12045959)
Timothy D. W. Claridge (7732220)
Rachel Tanner (3552449)
David Leppert (19992)
Jacqueline Palace (25665)
Jens Kuhle (346208)
Fay Probert (849357)
Daniel C. Anthony (8462202)

October 2022

Additional file 2: Fig. S2 CSF and serum NfL concentrations in control and naïve animals. No differe...

Additional file 1: of Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia

Pooja-Shree Mishra (3501329)
K. Vijayalakshmi (2015191)
A. Nalini (3501335)
T. Sathyaprabha (3501323)
B. Kramer (4690003)
Phalguni Alladi (3501326)
T. Raju (556903)

December 2017

Details of the CSF samples taken for the study. Table S1 describes the age and gender of the subject...

Additional file 1: of Unique RNA signature of different lesion types in the brain white matter in progressive multiple sclerosis

Maria Elkjaer (6637157)
Tobias Frisch (6637163)
Richard Reynolds (782370)
Tim Kacprowski (793348)
Mark Burton (489123)
Torben Kruse (849728)
Mads Thomassen (395200)
Jan Baumbach (14867)
Zsolt Illes (441094)

April 2019

Table S1. Clinical and demographic data of the MS patients and non-neurological disease controls (PD...

Additional file 2: of Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients

Ester Canto (4920835)
Noriko Isobe (119848)
Alessandro Didonna (4920832)
Stephen Hauser (591884)
Jorge Oksenberg (488201)

March 2018

Table S1. Comparison of levels of phosphorylated proteins between MS patients and controls in baseli...

Additional file 2: of Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder

Kazuya Yamashita (4573810)
Makoto Kinoshita (2566)
Katsuichi Miyamoto (5151443)
Akiko Namba (4573804)
Mikito Shimizu (4573801)
Toru Koda (439309)
Tomoyuki Sugimoto (339575)
Yuki Mori (181478)
Yoshichika Yoshioka (181477)
Yuji Nakatsuji (339577)
Atsushi Kumanogoh (50659)
Susumu Kusunoki (633553)
Hideki Mochizuki (204792)
Tatsusada Okuno (339570)

April 2018

Table S1. Clinical and CSF characteristics of patients with similar CSF counts. Table S2. Clinical a...

Biomarkers and Disease Activity in Multiple Sclerosis : A cohort study on patients with clinically isolated syndrome and relapsing remitting multiple sclerosis

Håkansson, Irene

January 2019

This thesis focuses on disease activity in clinically isolated syndrome (CIS) and newly diagnosed re...

Additional file 5: of Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients

Ester Canto (4920835)
Noriko Isobe (119848)
Alessandro Didonna (4920832)
Stephen Hauser (591884)
Jorge Oksenberg (488201)

March 2018

Table S4. Comparison of levels of p38MAPK, Erk1/2, STAT1, and STAT6 between MS patients and controls...

Plasma neurofilaments correlate with disability in progressive multiple sclerosis patients

Ferraro, Diana
Guicciardi, Claudio
De Biasi, Sara
Pinti, Marcello
Bedin, Roberta
Camera, Valentina
Vitetta, Francesca
Nasi, Milena
Meletti, Stefano
Sola, Patrizia

January 2020

Cerebrospinal fluid (CSF) and blood neurofilaments (NFLs) are markers of axonal damage and are being...

Additional file 2: Table S2. of Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis

Michael Gurevich (128754)
Gadi Miron (3430016)
Rina Zilkha Falb (3430013)
David Magalashvili (128751)
Mark Dolev (128752)
Yael Stern (440380)
Anat Achiron (71228)

November 2015

List of DEGs characterizing SPMS untreated vs. RRMS untreated patients. (XLSX 21 kb

Additional file 1 of Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias

Giuseppe Mario Bentivenga (13946676)
Simone Baiardi (3544532)
Andrea Mastrangelo (11594374)
Corrado Zenesini (781399)
Angela Mammana (2160655)
Barbara Polischi (4796133)
Sabina Capellari (324583)
Piero Parchi (324582)

September 2023

Additional file 1: Supplementary material. Supplementary methods, probable sCJD and np-RPD patients’...

Additional file 2: of Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis

Irene HĂĽkansson (5534792)
Anders Tisell (307389)
Petra Cassel (5534786)
Kaj Blennow (58615)
Henrik Zetterberg (144718)
Peter Lundberg (307397)
Charlotte Dahle (307394)
Magnus Vrethem (307399)
Jan Ernerudh (45215)

July 2018

Table S2. Neuroinflammatory and neurodegenerative markers with respect to separation of patients wit...

Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis

Håkansson, Irene
Tisell, Anders
Cassel, Petra
Blennow, Kaj
Zetterberg, Henrik
Lundberg, Peter
Dahle, Charlotte
Vrethem, Magnus
Ernerudh, Jan

January 2018

Background: There is a need for clinically useful biomarkers of disease activity in clinically isola...

Additional file 1: of Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study

M. Olesen (6446813)
K. Soelberg (6446816)
B. Debrabant (6446819)
A. Nilsson (4329301)
S. Lillevang (6446825)
J. Grauslund (6446828)
I. Brandslund (6446831)
J. Madsen (2052997)
F. Paul (4171135)
T. Smith (3484139)
S. Jarius (4171156)
N. Asgari (6446834)

March 2019

Figure S1. Correlation between intrathecal markers in isolated optic neuritis. This figure depicts t...

Additional file 2: of Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study

M. Olesen (6446813)
K. Soelberg (6446816)
B. Debrabant (6446819)
A. Nilsson (4329301)
S. Lillevang (6446825)
J. Grauslund (6446828)
I. Brandslund (6446831)
J. Madsen (2052997)
F. Paul (4171135)
T. Smith (3484139)
S. Jarius (4171156)
N. Asgari (6446834)

March 2019

Table S1. Logistic regression analyses for single predictors. Highlighted in bold are p values for w...

Additional file 3: of Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study

M. Olesen (6446813)
K. Soelberg (6446816)
B. Debrabant (6446819)
A. Nilsson (4329301)
S. Lillevang (6446825)
J. Grauslund (6446828)
I. Brandslund (6446831)
J. Madsen (2052997)
F. Paul (4171135)
T. Smith (3484139)
S. Jarius (4171156)
N. Asgari (6446834)

March 2019

Figure S2. Receiver-operating characteristic (ROC) curves for the six individual predictors that wer...

Additional file 2 of Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model

Tianrong Yeo (4664314)
Halwan Bayuangga (13931168)
Marcus Augusto-Oliveira (5565137)
Megan Sealey (12045959)
Timothy D. W. Claridge (7732220)
Rachel Tanner (3552449)
David Leppert (19992)
Jacqueline Palace (25665)
Jens Kuhle (346208)
Fay Probert (849357)
Daniel C. Anthony (8462202)

October 2022

Additional file 2: Fig. S2 CSF and serum NfL concentrations in control and naïve animals. No differe...

Additional file 1: of Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia

Pooja-Shree Mishra (3501329)
K. Vijayalakshmi (2015191)
A. Nalini (3501335)
T. Sathyaprabha (3501323)
B. Kramer (4690003)
Phalguni Alladi (3501326)
T. Raju (556903)

December 2017

Details of the CSF samples taken for the study. Table S1 describes the age and gender of the subject...

Additional file 1: of Unique RNA signature of different lesion types in the brain white matter in progressive multiple sclerosis

Maria Elkjaer (6637157)
Tobias Frisch (6637163)
Richard Reynolds (782370)
Tim Kacprowski (793348)
Mark Burton (489123)
Torben Kruse (849728)
Mads Thomassen (395200)
Jan Baumbach (14867)
Zsolt Illes (441094)

April 2019

Table S1. Clinical and demographic data of the MS patients and non-neurological disease controls (PD...

Additional file 2: of Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients

Ester Canto (4920835)
Noriko Isobe (119848)
Alessandro Didonna (4920832)
Stephen Hauser (591884)
Jorge Oksenberg (488201)

March 2018

Table S1. Comparison of levels of phosphorylated proteins between MS patients and controls in baseli...

Additional file 2: of Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder

Kazuya Yamashita (4573810)
Makoto Kinoshita (2566)
Katsuichi Miyamoto (5151443)
Akiko Namba (4573804)
Mikito Shimizu (4573801)
Toru Koda (439309)
Tomoyuki Sugimoto (339575)
Yuki Mori (181478)
Yoshichika Yoshioka (181477)
Yuji Nakatsuji (339577)
Atsushi Kumanogoh (50659)
Susumu Kusunoki (633553)
Hideki Mochizuki (204792)
Tatsusada Okuno (339570)

April 2018

Table S1. Clinical and CSF characteristics of patients with similar CSF counts. Table S2. Clinical a...

Biomarkers and Disease Activity in Multiple Sclerosis : A cohort study on patients with clinically isolated syndrome and relapsing remitting multiple sclerosis

Håkansson, Irene

January 2019

This thesis focuses on disease activity in clinically isolated syndrome (CIS) and newly diagnosed re...

Additional file 5: of Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients

Ester Canto (4920835)
Noriko Isobe (119848)
Alessandro Didonna (4920832)
Stephen Hauser (591884)
Jorge Oksenberg (488201)

March 2018

Table S4. Comparison of levels of p38MAPK, Erk1/2, STAT1, and STAT6 between MS patients and controls...

Plasma neurofilaments correlate with disability in progressive multiple sclerosis patients

Ferraro, Diana
Guicciardi, Claudio
De Biasi, Sara
Pinti, Marcello
Bedin, Roberta
Camera, Valentina
Vitetta, Francesca
Nasi, Milena
Meletti, Stefano
Sola, Patrizia

January 2020

Cerebrospinal fluid (CSF) and blood neurofilaments (NFLs) are markers of axonal damage and are being...

Additional file 2: Table S2. of Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis

Michael Gurevich (128754)
Gadi Miron (3430016)
Rina Zilkha Falb (3430013)
David Magalashvili (128751)
Mark Dolev (128752)
Yael Stern (440380)
Anat Achiron (71228)

November 2015

List of DEGs characterizing SPMS untreated vs. RRMS untreated patients. (XLSX 21 kb

Additional file 1 of Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias

Giuseppe Mario Bentivenga (13946676)
Simone Baiardi (3544532)
Andrea Mastrangelo (11594374)
Corrado Zenesini (781399)
Angela Mammana (2160655)
Barbara Polischi (4796133)
Sabina Capellari (324583)
Piero Parchi (324582)

September 2023

Additional file 1: Supplementary material. Supplementary methods, probable sCJD and np-RPD patients’...

Additional file 1: of Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis

Abstract

Extracted data

Additional file 1: of Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis

Abstract

Extracted data

Related items

Related items